ニュース
Quantitative proteomics Microarray technology is finding its way into quantitative proteomics through the construction of what are most accurately called 'protein-detecting microarrays' 1.
The microarray is a very recent development in the field of biotechnology. Scientists are now able to understand the gene functions of any organism by tracking down thousands of genes and their ...
Microarray technology is now widely available and is being applied to address increasingly complex scientific questions. Consequently, there is a greater demand for statistical assessment of the ...
The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...
The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results ...
Courtesy of CombiMatrix The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading ...
Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a C ...
The microarray is a recently developed technology used in cancer research and in the pharmacological treatment of other diseases such as oral lesions. In this technology, a microscope slide ...
The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities. Customers will benefit ...
Microarrays in a Microtube Image courtesy of CLONDIAG Companies in the microarray sector are trying to take the technology out of core facilities and put it into the hands of individual researchers by ...
The acquisition of the Arizona-based microarray solutions company extends Schott’s manufacturing presence in the United States and strengthens its bioscience capabilities. Customers will benefit from ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する